Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company"s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
Website: abbott.com



Growth: Pretty weak revenue growth rate 6.9%, there is acceleration compared to average historical growth rates -0.5%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -15.6%

Profitability: LTM EBITDA margin is positive, +20.8%. On average the margin is improving unsteadily. Gross margin is high, +55.8%. In the last quarter the company beat the estimated EPS, +4.4%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.19 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 2.2%. Free cash flow yield 1.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 22.0% higher than minimum and 21.5% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.6x by EV / Sales multiple , the company can be 42.8% overvalued

Insiders: For the last 3 months insiders bought company shares on $1.8 mln (0.001% of cap.)

Key Financials (Download financials)

Ticker: ABT
Share price, USD:  (+0.7%)110.04
year average price 129.40  


year start price 128.45 2025-02-03

max close price 140.22 2025-03-03

min close price 106.05 2026-01-28

current price 110.04 2026-02-02
Common stocks: 1 746 881 140

Dividend Yield:  2.2%
FCF Yield LTM: 1.0%
EV / LTM EBITDA: 21.7x
EV / EBITDA annualized: 20.2x
Last revenue growth (y/y):  +6.9%
Last growth of EBITDA (y/y):  +10.9%
Historical revenue growth:  -0.5%
Historical growth of EBITDA:  -2.5%
EV / Sales: 4.5x
Margin (EBITDA LTM / Revenue): 20.8%
Fundamental value created in LTM:
Market Cap ($m): 192 227
Net Debt ($m): 5 564
EV (Enterprise Value): 197 791
Price to Book: 3.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-02-02seekingalpha.com

Abbott: Long-Term Investment Opportunity For Dividend Growth Investors

2026-01-31fool.com

Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist

2026-01-25seekingalpha.com

Abbott Laboratories: Double-Digit Earnings Growth Makes It A Buy

2026-01-24marketbeat.com

Is Abbott's January Pullback a Good Time to Buy?

2026-01-24seekingalpha.com

Abbott Laboratories: The Market's Overreaction Is The Long-Term Investor's Opportunity

2026-01-23zacks.com

Abbott (ABT) is a Top-Ranked Value Stock: Should You Buy?

2026-01-23forbes.com

Is The Fall In Abbott Stock Justified?

2026-01-23seekingalpha.com

Abbott Laboratories: Buy This Dividend King On Sale Now

2026-01-23reuters.com

Abbott faces India scrutiny in cough syrup abuse investigation, documents show

2026-01-22wsj.com

Abbott Laboratories Raised Prices, Prompting Sales Slump
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q4 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-12-31 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800
filingDate 2026-01-22 2025-02-21 2024-02-16 2023-02-17 2022-02-18 2021-02-19
acceptedDate 2026-01-22 02:35:00 2025-10-29 16:22:25 2025-07-30 16:14:29 2025-02-21 16:07:20 2024-10-31 17:14:00 2024-07-31 16:02:17 2024-05-02 16:11:10 2024-02-16 16:15:58 2023-11-01 16:07:32 2023-08-03 16:07:28 2023-05-04 16:03:45 2023-02-17 16:09:44 2022-11-01 16:06:19 2022-02-18 16:02:57 2021-02-19 16:10:04
fiscalYear 2025 2024 2023 2022 2021 2020
period FY Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 44 328M 11 369M 11 142M 41 950M 10 635M 10 377M 9 964M 40 109M 10 143M 9 978M 9 747M 43 653M 10 410M 43 075M 34 608M
costOfRevenue 19 721M 5 031M 4 854M 20 625M 4 698M 4 570M 4 420M 20 072M 4 605M 4 483M 4 331M 21 330M 4 629M 19 861M 17 231M
grossProfit 24 607M 6 338M 6 288M 21 325M 5 937M 5 807M 5 544M 20 037M 5 538M 5 495M 5 416M 22 323M 5 781M 23 214M 17 377M
researchAndDevelopmentExpenses 2 955M 785M 732M 2 823M 713M 698M 679M 2 719M 672M 715M 654M 2 852M 782M 2 738M 2 418M
generalAndAdministrativeExpenses 12 378M 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 12 378M 3 103M 3 093M 11 651M 2 895M 2 915M 2 943M 10 883M 2 601M 2 740M 2 762M 11 109M 2 731M 11 276M 9 668M
otherExpenses 1 253M 420M 411M 0 470M -471M -472M 0 83M 498M 491M 0 498M 0 0
operatingExpenses 16 586M 4 308M 4 236M 14 474M 4 078M 4 084M 4 094M 13 602M 3 798M 3 953M 3 907M 13 961M 4 011M 14 014M 12 086M
costAndExpenses 36 280M 9 339M 9 090M 35 099M 8 776M 8 654M 8 514M 33 674M 8 403M 8 436M 8 238M 35 291M 8 640M 33 875M 29 317M
netInterestIncome -111M -259M -313M -132M -367M -662M
interestIncome 230M 77M 71M 344M 91M 82M 80M 385M 69M 98M 101M 183M 55M 43M 46M
interestExpense 341M 44M 121M 603M 142M 58M 61M 698M 166M 61M 52M 315M 141M 410M 708M
depreciationAndAmortization 2 746M 791M 777M 3 218M 801M 805M 805M 3 243M 824M 674M 602M 3 267M 944M 3 538M 3 327M
ebitda 11 332M 3 015M 3 048M 10 834M 2 907M 2 638M 1 450M 10 605M 2 593M 2 216M 2 111M 11 888M 2 714M 12 159M 9 003M
ebit 8 586M 7 616M 7 362M 8 621M 8 621M 5 676M
nonOperatingIncomeExcludingInterest -538M -765M -927M -259M 579M -385M
operatingIncome 8 048M 2 030M 2 052M 6 825M 1 859M 1 723M 1 450M 6 435M 1 769M 1 542M 1 509M 8 362M 1 770M 9 200M 5 291M
totalOtherIncomeExpensesNet 418M 150M 98M 188M 81M -62M -14M 229M -98M 94M 53M -56M -12M -989M -323M
incomeBeforeTax 8 466M 2 180M 2 150M 7 013M 1 940M 1 607M 1 436M 6 664M 1 671M 1 636M 1 562M 8 306M 1 758M 8 211M 4 968M
incomeTaxExpense 1 942M 536M 371M -6 389M 294M 305M 211M 941M 235M 261M 244M 1 373M 323M 1 140M 497M
netIncomeFromContinuingOperations 6 524M 13 402M 5 723M 6 933M 7 071M 4 471M
netIncomeFromDiscontinuedOperations 0 0 0 0 0 24M
otherAdjustmentsToNetIncome 0 0 0 0 0 0
netIncome 6 524M 1 644M 1 779M 13 402M 1 646M 1 302M 1 225M 5 723M 1 436M 1 375M 1 318M 6 933M 1 435M 7 071M 4 495M
netIncomeDeductions 0 0 0 0 0 0
bottomLineNetIncome 6 524M 13 402M 5 723M 6 933M 7 071M 4 495M
eps 3.74 0.94 1.02 7.67 0.95 0.75 0.71 3.3 0.83 0.79 0.76 3.94 1.15 3.97 2.52
epsDiluted 3.72 7.64 3.27 3.91 3.94 2.5
weightedAverageShsOut 1 747M 1 749M 1 740M 1 732M 1 734M 1 734M 1 734M 1 734M 1 739M 1 739M 1 738M 1 753M 1 248M 1 775M 1 773M
weightedAverageShsOutDil 1 747M 1 749M 1 751M 1 748M 1 748M 1 751M 1 750M 1 749M 1 748M 1 750M 1 752M 1 764M 1 764M 1 789M 1 786M
fillingDate 2025-10-29 2025-07-30 2024-10-31 2024-07-31 2024-05-02 2023-11-01 2023-08-03 2023-05-04 2022-11-01
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
grossProfitRatio 0.557 0.564 0.558 0.56 0.556 0.546 0.551 0.556 0.555
ebitdaratio 0.265 0.274 0.273 0.166 0.146 0.256 0.222 0.217 0.261
operatingIncomeRatio 0.179 0.184 0.175 0.166 0.146 0.174 0.155 0.155 0.17
incomeBeforeTaxRatio 0.192 0.193 0.182 0.155 0.144 0.165 0.164 0.16 0.169
netIncomeRatio 0.145 0.16 0.155 0.125 0.123 0.142 0.138 0.135 0.138
epsdiluted 0.94 1.01 0.94 0.74 0.7 0.82 0.78 0.75 0.81
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2025 q1 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800
fillingDate 2025-10-29 2025-07-30 2025-04-30 2024-10-31 2024-07-31 2024-05-02 2023-11-01 2023-08-03 2023-05-04 2022-11-01
acceptedDate 2025-10-29 16:22:25 2025-07-30 16:14:29 2025-04-30 16:14:32 2025-02-21 16:07:20 2024-10-31 17:14:00 2024-07-31 16:02:17 2024-05-02 16:11:10 2024-02-16 16:15:58 2023-11-01 16:07:32 2023-08-03 16:07:28 2023-05-04 16:03:45 2023-02-17 16:09:44 2022-11-01 16:06:19 2022-02-18 16:02:57 2021-02-19 16:10:04
calendarYear 2025 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 7 511M 6 951M 6 532M 7 616M 7 558M 6 987M 6 284M 6 896M 6 709M 7 835M 9 882M 9 882M 9 594M 9 799M 6 838M
shortTermInvestments 222M 331M 312M 351M 230M 232M 367M 383M 338M 320M 288M 288M 313M 450M 310M
cashAndShortTermInvestments 7 733M 7 282M 6 844M 7 967M 7 788M 7 219M 6 651M 7 279M 7 047M 8 155M 10 170M 10 170M 9 907M 10 249M 7 148M
netReceivables 10 398M 10 232M 7 327M 6 925M 9 201M 6 854M 6 605M 6 565M 8 967M 8 479M 8 172M 6 218M 6 408M 6 487M 6 414M
inventory 6 708M 6 954M 6 639M 6 194M 6 813M 6 814M 6 827M 6 570M 6 650M 6 871M 6 173M 6 173M 5 734M 5 157M 5 012M
otherCurrentAssets 0 0 2 343M 2 570M 0 4 254M 2 293M 2 256M 8 967M 8 479M 8 881M 2 663M 2 796M 2 346M 1 867M
totalCurrentAssets 24 839M 24 468M 23 153M 23 656M 23 802M 23 119M 22 376M 22 670M 22 664M 23 505M 25 224M 25 224M 24 845M 24 239M 20 441M
propertyPlantEquipmentNet 11 504M 11 395M 10 932M 11 733M 10 621M 10 233M 10 107M 11 276M 9 552M 9 449M 9 162M 10 278M 8 689M 10 112M 10 130M
goodwill 23 971M 23 952M 23 359M 23 108M 23 658M 23 308M 23 383M 23 679M 23 277M 23 258M 22 799M 22 799M 22 284M 23 231M 23 744M
intangibleAssets 5 594M 5 920M 6 261M 6 647M 7 352M 7 827M 8 296M 8 815M 9 282M 9 834M 10 454M 10 454M 10 850M 12 739M 14 784M
goodwillAndIntangibleAssets 29 565M 29 872M 29 620M 29 755M 31 010M 31 135M 31 679M 32 494M 32 559M 33 092M 33 253M 33 253M 33 134M 35 970M 38 528M
longTermInvestments 951M 958M 907M 886M 912M 877M 818M 799M 788M 799M 766M 766M 764M 903M 1 031M
taxAssets 0 0 0 0 0 7 653M 7 487M 0 6 527M 6 509M 6 033M 0 5 369M 0 0
otherNonCurrentAssets 17 318M 17 306M 16 836M 15 384M 8 011M 0 0 5 975M 0 0 0 4 917M 0 3 972M 2 418M
totalNonCurrentAssets 59 338M 59 531M 58 295M 57 758M 50 554M 49 898M 50 091M 50 544M 49 426M 49 849M 49 214M 49 214M 47 956M 50 957M 52 107M
otherAssets 4M 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 84 181M 83 999M 81 448M 81 414M 74 356M 73 017M 72 467M 73 214M 72 090M 73 354M 74 438M 74 438M 72 801M 75 196M 72 548M
accountPayables 4 123M 4 306M 4 214M 4 195M 4 034M 4 125M 4 178M 4 295M 3 961M 4 211M 4 607M 4 607M 4 133M 4 408M 3 946M
shortTermDebt 1 345M 507M 506M 1 754M 2 154M 1 615M 2 010M 1 325M 1 051M 2 284M 2 251M 2 481M 1 117M 999M 461M
taxPayables 469M 390M 485M 594M 713M 601M 562M 492M 318M 273M 343M 343M 394M 306M 362M
deferredRevenue 0 0 0 0 0 601M 562M 0 318M 273M 0 0 0 0 0
otherCurrentLiabilities 8 645M 8 236M 7 799M 5 913M 8 001M 7 419M 7 271M 6 132M 7 712M 7 582M 8 631M 6 502M 8 115M 5 767M 5 722M
totalCurrentLiabilities 14 582M 13 439M 13 004M 14 157M 14 902M 13 760M 14 021M 13 841M 13 042M 14 350M 15 489M 15 489M 13 365M 13 105M 11 907M
longTermDebt 11 596M 12 930M 12 736M 12 625M 12 825M 13 139M 12 576M 13 599M 14 477M 14 562M 14 522M 14 522M 15 297M 17 296M 18 527M
deferredRevenueNonCurrent 0 0 0 0 0 -6 558M -6 827M 0 -6 877M -7 038M -7 417M 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 1 372M 0 6 558M 6 827M 1 218M 6 877M 7 038M 7 522M 1 841M 0 2 072M 2 146M
otherNonCurrentLiabilities 6 739M 6 801M 6 644M 4 463M 6 601M 6 558M 6 827M 4 780M 6 877M 7 038M 7 417M 4 738M 18 302M 5 743M 6 063M
totalNonCurrentLiabilities 18 335M 19 731M 19 380M 19 356M 19 426M 19 697M 19 403M 20 546M 21 354M 21 600M 22 044M 22 044M 23 552M 26 067M 27 638M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 -971M 0 0 0 0
capitalLeaseObligations 0 0 0 896M 0 0 0 949M 0 0 0 943M 8 255M 956M 902M
totalLiabilities 32 917M 33 170M 32 384M 33 513M 34 328M 33 457M 33 424M 34 387M 34 396M 35 950M 36 562M 37 533M 36 917M 39 172M 39 545M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 25 412M 25 284M 25 125M 25 153M 25 020M 24 858M 24 726M 24 869M 24 727M 24 612M 24 709M 24 709M 24 560M 24 470M 24 145M
retainedEarnings 49 103M 48 467M 47 715M 47 261M 39 056M 38 354M 38 011M 37 554M 36 920M 36 355M 35 868M 35 257M 35 115M 31 528M 27 627M
accumulatedOtherComprehensiveIncomeLoss -6 684M -6 576M -7 417M -7 906M -7 804M -8 135M -8 166M -7 839M -8 480M -8 071M -8 051M -8 051M -9 445M -8 374M -8 946M
othertotalStockholdersEquity -16 877M -16 610M -16 612M -16 476M -15 759M -15 761M -15 686M -15 722M 21 693M -14 555M
totalStockholdersEquity 50 954M 50 565M 48 811M 47 664M 39 796M 39 318M 38 810M 38 603M 37 481M 37 174M 74 219M 36 686M 35 675M 35 802M 32 784M
totalEquity 51 264M 50 829M 49 064M 47 901M 40 028M 39 560M 39 043M 38 827M 37 694M 37 404M 74 219M 36 905M 35 675M 36 024M 33 003M
totalLiabilitiesAndStockholdersEquity 84 181M 83 999M 81 448M 74 356M 73 017M 72 467M 72 090M 73 354M 74 438M 72 801M
minorityInterest 310M 264M 253M 237M 232M 242M 233M 224M 213M 230M 222M 219M 0 222M 219M
totalLiabilitiesAndTotalEquity 84 181M 83 999M 81 448M 81 414M 74 356M 73 017M 72 467M 73 214M 72 090M 73 354M 74 438M 74 438M 72 801M 75 196M 72 548M
totalInvestments 1 173M 1 289M 1 219M 1 237M 1 142M 1 109M 1 185M 1 182M 1 126M 1 119M 1 054M 1 054M 1 077M 1 353M 1 341M
totalDebt 12 941M 13 437M 13 242M 15 275M 14 979M 14 754M 14 586M 15 873M 15 528M 16 846M 16 773M 17 946M 16 414M 19 251M 19 890M
netDebt 5 430M 6 486M 6 710M 7 659M 7 421M 7 767M 8 302M 8 977M 8 819M 9 011M 6 891M 8 064M 6 820M 9 452M 13 052M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-02-21 2024-02-16 2023-02-17 2022-02-18 2021-02-19
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 6 925M 6 565M 6 218M 6 487M 6 414M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 0 0
totalPayables 4 789M 4 787M 4 950M 4 714M 4 308M
otherPayables 594M 492M 343M 306M 362M
accruedExpenses 1 701M 1 597M 1 556M 1 625M 1 416M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 896M 949M 943M 956M 902M
treasuryStock -16 844M -15 981M -15 229M -11 822M -10 042M
additionalPaidInCapital 0 0 0 0 0
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2025 q1 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT ABT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800 1800
fillingDate 2025-10-29 2025-07-30 2025-04-30 2024-10-31 2024-07-31 2024-05-02 2023-11-01 2023-08-03 2023-05-04 2022-11-01
acceptedDate 2025-10-29 16:22:25 2025-07-30 16:14:29 2025-04-30 16:14:32 2025-02-21 16:07:20 2024-10-31 17:14:00 2024-07-31 16:02:17 2024-05-02 16:11:10 2024-02-16 16:15:58 2023-11-01 16:07:32 2023-08-03 16:07:28 2023-05-04 16:03:45 2023-02-17 16:09:44 2022-11-01 16:06:19 2022-02-18 16:02:57 2021-02-19 16:10:04
calendarYear 2025 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 1 644M 1 779M 1 325M 13 402M 1 640M 1 297M 1 220M 5 723M 1 436M 1 375M 1 318M 6 933M 1 435M 7 071M 4 495M
depreciationAndAmortization 791M 777M 756M 3 218M 801M 805M 805M 3 243M 824M 800M 806M 3 267M 815M 3 538M 3 327M
deferredIncomeTax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
stockBasedCompensation 120M 142M 289M 673M 117M 141M 304M 644M 117M 132M 281M 685M 123M 640M 546M
changeInWorkingCapital 11M -407M -517M -9 217M 141M -288M -1 309M -2 475M -321M -444M -186M -1 519M 336M -771M -892M
accountsReceivables -202M -410M -262M -691M 0 -325M -151M -356M -461M -196M 233M -68M 530M -383M -924M
inventory 213M 3M -255M -58M 220M -103M -410M -232M 140M -248M -419M -1 413M -194M -456M -493M
accountsPayables 0 0 0 356M 0 0 0 -760M 179M 0 0 420M 0 1 288M 1 766M
otherWorkingCapital 0 0 0 -8 824M -79M 140M -748M -1 127M -179M 0 186M -458M 0 -1 220M -1 241M
otherNonCashItems 221M -244M -436M 482M 6M 2 184M 2 480M 126M -179M -660M -1 076M 215M 71M 55M 425M
netCashProvidedByOperatingActivities 2 787M 2 047M 1 417M 8 558M 2 705M 1 960M 1 025M 7 261M 1 877M 1 203M 1 143M 9 581M 2 780M 10 533M 7 901M
investmentsInPropertyPlantAndEquipment -496M -502M -484M -2 207M 0 -533M -398M -2 202M -560M -507M -380M -1 777M -467M -1 885M -2 177M
acquisitionsNet -55M 0 0 1 000 000 -1 000 000 1 000 000 0 -837M -51M 0 0 48M 0 -53M 16M
purchasesOfInvestments 0 0 0 -169M 9M 28M -28M -159M -38M 0 -86M -185M 0 -173M -83M
salesMaturitiesOfInvestments 0 0 0 28M -40M 49M 0 43M 38M 0 0 152M 0 77M 10M
otherInvestingActivites 94M -80M 14M -562M 2M 1 000 000 -23M -706M 4M -17M
netCashUsedForInvestingActivites -457M -582M -470M -594M -453M -425M -634M -1 213M -462M -484M
debtRepayment -493M -15M -1 036M 43M 160M -127M -1 445M -2M 0 -1 000 000
commonStockIssued 0 0 0 0 0 134M 56M 0 0 0
commonStockRepurchased -305M -6M -280M -1 295M -751M -3M -226M -1 227M -2M -426M -540M -3 795M -798M -2 299M -403M
dividendsPaid -1 031M -1 029M -1 026M -960M -961M -957M -888M -890M -890M -826M
otherFinancingActivites 69M -47M 287M 92M 13M 7M -61M 29M 20M 82M
netCashUsedProvidedByFinancingActivities -1 760M -1 097M -2 055M -1 576M -791M -1 176M -2 340M -1 289M -1 410M -1 543M
effectOfForexChangesOnCash -10M 51M 24M -96M 36M -13M -36M -23M -29M -27M 8M -122M -96M -70M 71M
netChangeInCash 560M 419M -1 084M 720M 571M 703M -612M -2 986M -1 126M -1 326M -721M 83M 657M 2 961M 2 978M
cashAtEndOfPeriod 7 511M 6 951M 6 532M 7 616M 7 558M 6 987M 6 284M 6 896M 6 709M 7 835M 9 161M 9 882M 9 594M 9 799M 6 838M
cashAtBeginningOfPeriod 6 951M 6 532M 7 616M 6 896M 6 987M 6 284M 6 896M 9 882M 7 835M 9 161M 9 882M 9 799M 8 937M 6 838M 3 860M
operatingCashFlow 2 787M 2 047M 1 417M 8 558M 2 705M 1 960M 1 025M 7 261M 1 877M 1 203M 1 143M 9 581M 2 780M 10 533M 7 901M
capitalExpenditure -496M -502M -484M -2 207M -556M -533M -398M -2 202M -560M -507M -380M -1 777M -467M -1 885M -2 177M
freeCashFlow 2 291M 1 545M 933M 6 351M 2 149M 1 427M 627M 5 059M 1 317M 696M 763M 7 804M 2 313M 8 648M 5 724M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-02-21 2024-02-16 2023-02-17 2022-02-18 2021-02-19
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 9M 22M 22M 26M 19M
netCashProvidedByInvestingActivities -2 338M -3 133M -1 740M -2 008M -2 215M
netDebtIssuance -537M -2 475M -699M -248M -50M
longTermNetDebtIssuance -437M -2 496M -746M -44M -52M
shortTermNetDebtIssuance -100M 21M 47M -204M 2M
netStockIssuance -1 295M -1 227M -3 795M -2 299M -403M
netCommonStockIssuance -1 295M -1 227M -3 795M -2 299M -403M
commonStockIssuance 0 0 0 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -3 836M -3 556M -3 309M -3 202M -2 560M
commonDividendsPaid -3 836M -3 556M -3 309M -3 202M -2 560M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 264M 167M 167M 255M 234M
netCashProvidedByFinancingActivities -5 404M -7 091M -7 636M -5 494M -2 779M
incomeTaxesPaid 1 723M 1 475M 1 864M 1 941M 970M
interestPaid 604M 662M 563M 544M 549M

Earning call transcript

2025 q4
2026-01-22 ET (fiscal 2025 q4)
2025 q3
2025-10-15 ET (fiscal 2025 q3)
2025 q2
2025-07-17 ET (fiscal 2025 q2)
2025 q1
2025-04-16 ET (fiscal 2025 q1)
2024 q4
2025-01-22 ET (fiscal 2024 q4)
2024 q3
2024-10-16 ET (fiscal 2024 q3)
2024 q2
2024-07-18 ET (fiscal 2024 q2)
2024 q1
2024-04-17 ET (fiscal 2024 q1)
2023 q4
2024-01-24 ET (fiscal 2023 q4)
2023 q3
2023-10-18 ET (fiscal 2023 q3)
2023 q2
2023-07-20 ET (fiscal 2023 q2)
2023 q1
2023-04-19 ET (fiscal 2023 q1)
2022 q4
2023-01-25 ET (fiscal 2022 q4)
2022 q3
2022-10-19 ET (fiscal 2022 q3)
2022 q2
2022-07-20 ET (fiscal 2022 q2)
2022 q1
2022-04-20 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-01-22 07:35 ET
Abbott reported for 2025 q4
SEC form 8
2026-01-22 07:35 ET
Abbott reported for 2025 q4
SEC form 10
2025-10-29 20:22 ET
Abbott reported for 2025 q3
SEC form 8
2025-10-15 11:33 ET
Abbott reported for 2025 q3
SEC form 8
2025-10-15 11:33 ET
Abbott reported for 2025 q3
SEC form 10
2025-07-30 20:14 ET
Abbott reported for 2025 q2
SEC form 8
2025-07-17 00:00 ET
Abbott reported for 2025 q2
SEC form 8
2025-07-17 00:00 ET
Abbott reported for 2025 q2
SEC form 10
2025-04-30 20:14 ET
Abbott published news for 2025 q1
SEC form 10
2025-04-30 00:00 ET
Abbott reported for 2025 q1
SEC form 8
2025-04-16 11:36 ET
Abbott reported for 2025 q1
SEC form 8
2025-04-16 11:36 ET
Abbott reported for 2025 q1
SEC form 10
2025-02-21 21:07 ET
Abbott published news for 2024 q4
SEC form 10
2025-02-21 00:00 ET
Abbott reported for 2024 q4
SEC form 8
2025-01-22 07:13 ET
Abbott published news for 2024 q4
SEC form 8
2025-01-22 07:13 ET
Abbott reported for 2024 q4
SEC form 10
2024-10-31 00:00 ET
Abbott reported for 2024 q3
SEC form 8
2024-10-16 07:37 ET
Abbott published news for 2024 q3
SEC form 8
2024-10-16 07:37 ET
Abbott published news for 2024 q3
SEC form 10
2024-07-31 00:00 ET
Abbott reported for 2024 q2
SEC form 8
2024-07-18 07:37 ET
Abbott published news for 2024 q2
SEC form 8
2024-07-18 07:37 ET
Abbott published news for 2024 q2
SEC form 10
2024-05-02 00:00 ET
Abbott reported for 2024 q1
SEC form 8
2024-04-17 07:36 ET
Abbott published news for 2024 q1
SEC form 8
2024-04-17 07:36 ET
Abbott reported for 2024 q1
SEC form 10
2024-02-16 16:15 ET
Abbott reported for 2023 q4
SEC form 10
2024-02-16 00:00 ET
Abbott reported for 2023 q4
SEC form 8
2024-01-24 07:36 ET
Abbott published news for 2023 q4
SEC form 8
2024-01-24 07:36 ET
Abbott published news for 2023 q4
SEC form 10
2023-11-01 00:00 ET
Abbott reported for 2023 q3
SEC form 8
2023-10-18 07:37 ET
Abbott published news for 2023 q3
SEC form 10
2023-08-03 00:00 ET
Abbott reported for 2023 q2
SEC form 6
2023-07-20 08:29 ET
Abbott published news for 2023 q2
SEC form 8
2023-07-20 00:00 ET
Abbott published news for 2023 q2
SEC form 6
2023-06-23 16:07 ET
Abbott published news for 2023 q1
SEC form 6
2023-06-12 10:32 ET
Abbott published news for 2023 q1
SEC form 6
2023-06-09 16:05 ET
Abbott published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Abbott reported for 2023 q1
SEC form 8
2023-04-19 00:00 ET
Abbott published news for 2023 q1
SEC form 10
2023-02-17 00:00 ET
Abbott reported for 2022 q4
SEC form 8
2023-01-25 00:00 ET
Abbott reported for 2022 q4
SEC form 10
2022-11-01 00:00 ET
Abbott reported for 2022 q3
SEC form 8
2022-10-19 00:00 ET
Abbott reported for 2022 q3
SEC form 10
2022-08-02 00:00 ET
Abbott reported for 2022 q2
SEC form 8
2022-07-20 00:00 ET
Abbott published news for 2022 q2
SEC form 10
2022-05-03 00:00 ET
Abbott reported for 2022 q1
SEC form 8
2022-04-20 00:00 ET
Abbott reported for 2022 q1
SEC form 10
2022-02-18 00:00 ET
Abbott published news for 2021 q4
SEC form 8
2022-01-26 00:00 ET
Abbott published news for 2021 q4
SEC form 10
2021-11-03 00:00 ET
Abbott published news for 2021 q3
SEC form 8
2021-10-20 00:00 ET
Abbott published news for 2021 q3
SEC form 10
2021-08-04 00:00 ET
Abbott published news for 2021 q2
SEC form 8
2021-07-22 00:00 ET
Abbott published news for 2021 q2
SEC form 10
2021-05-05 00:00 ET
Abbott published news for 2021 q1
SEC form 8
2021-04-20 00:00 ET
Abbott published news for 2021 q1